An Early Phase II Study of S-1 in Patients with Metastatic Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|171-178

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 171-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Uracil-Tegafur in Patients with Metastatic Pancreatic Cancer

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 223-227

Karger

Access to resources Recommend Favorite

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

A Phase II Study of Combined Chemotherapy with 5-Week Cycles of S-1 and CPT-11 plus Bevacizumab in Patients with Metastatic Colon Cancer

By  

Oncology, Vol. 85, Iss. 6, 2013-11 ,pp. : 317-322

Karger

Access to resources Recommend Favorite